News & Updates

Radiotherapy (RT) may be omitted in women ≥55 years of age with T1N0, grade 1 or 2, luminal A breast cancer who have been treated with breast-conserving surgery and endocrine therapy, due to the very low risk of 5-year local recurrence reported in a recent prospective cohort study.

Evidence on the association of weak opioids with a higher risk of oesophageal and colorectal cancer is not reliable, but there appears to be a small association with gastric cancer, suggests a study.

Novel systemic treatments are similarly effective in reducing the risk of progression or death in patients with metastatic hormone-sensitive (mHSPC) and castration-resistant prostate cancer (mCRPC), irrespective of visceral metastasis status, reports a study.

Prostate cancer treatment upends sexual function in men, but the good news is that supervised resistance and aerobic workout can counter these sexual side effects, according to a study presented at ASCO Breakthrough 2023.